AR 2007 Lo Res.pdf
Duramed's 250- Person Women's Healthcare Sales Force, which had been promoting the Plan B prescription- only product, is promoting the dual label Plan B OTC/ Rx to a professional audience that includes pharmacists, physicians and other healthcare providers. This team also markets the SEASONIQUE extended- cycle oral contraceptive, our ENJUVIA hormone therapy...
AR 2007 Lo Res.pdf page 16
Estrogen replacement therapy (ERT) - [Medication] - Quest Diagnostics Patient Health Library
Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Estrogen replacement therapy (ERT) - [Medication] - Quest Diagnostics Patient Health Library Estrogen replacement therapy (ERT) - [Medication] - Quest Diagnostics Patient Health Library Hormones, Sexual and reproductive organs, Sexual health, Women’s...
http://www.barrlabs.com/overview/annual/BRL_AR2002.pdf
The merger with Duramed gave Barr the proprietary Cenestin ® (Synthetic Conjugated Estrogens, A) product, a line of generic oral contraceptives, and access to the manufacturing capacity and packaging technologies necessary to efficiently produce oral contraceptive products. Carol B n- Maimon sid nt and Chi f Op rating Of fic r of Barr R s arch.
http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
PROPARACAINE HCL 2712 03-Aug-76 PHARMACIA AND UPJOHN INC "HEPARIN, SODIUM U.S.P." 2716 10-Aug-76 SMITHKLINE CORP "CIMETIDINE AND CIMETIDINE HCL MANUFACTURED IN CORK, IRELAND." 2719 09-Aug-76 PLANTEX LTD CHEM AND PHARM WORKS AMITRIPTYLINE HCL 2726 05-Aug-76 SCHERING AG NORETHINDRONE 2736 19-Jul-76 ROUSSEL-UCLAF "DEXAMETHASONE ACETATE ANHYDROUS USP MANUFACTURED IN VERTOLAYE, FRANCE."...
http://www.fda.gov/cder/dmf/xls/4Q2003ACTIVETYPE2EXCEL.xls
3M PHARMS CORDRAN (FLURANDRENOLIDE) TAPE ORGANICS DIV LA GRANGE INC ESTERIFIED ESTROGENS USP POWDER ORGANICS DIV LA GRANGE INC CONJUGATED ESTROGEN USP POWDER GANES CHEMICALS INC PROPOXYPHENE HYDROCHLORIDE AVENTIS PHARMA SA HYDROCORTISONE USP MALLINCKRODT INC OXYCODONE TEREPHTHALATE SOLMAG S.P.A CLIDINIUM BROMIDE PLIVA PHARMACEUTICAL CHEMICAL FOOD & COSMETIC INDUSTRY...
http://www.fda.gov/cder/guidance/guidlist.pdf
htm 301- 827- 4573 301- 827- 4577 Internet (I): E- mail: Tuesday, January 20, 2004 Table of Contents (by Subject Category) Current Good Manufacturing Practices Page 7 Page 9 Page 14 Page 14 Page 16 Page 17 Page 19 Page 23 Page 24 Page 25 Page 25 Page 26 Page 16 Page 18 Page 29 Advertising Page 3 Biopharmaceutics Page 3 Page 4 Chemistry Clinical Antimicrobial Clinical Medical Clinical...
Site Index: A-F
Food and Drug Administration Center for Drug Evaluation and Research Site Index Search CDER Index A-F A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Adverse Reactions Adverse Events Reporting System AERS Electronic Submissions Enforcement of the Postmarketing Adverse Drug Experience Reporting Regulations How to Report Medwatch Advisory Committee and Panel Meetings...
author: Paul Stauffer
Conjugated Estrogens, USP-LC-MS Method for Both Qualitative Chemical Characterization and Documentation of Qualitative
Analyze these solutions separately using the gradient LC-MS method to define the three most abundant estrogen sulfates in Conjugated Estrogens, USP, by comparing the retention times (RTs) to the three most abundant components in Conjugated Estrogens, USP, reference standard tablets or to the pioneer Conjugated Estrogens Tablets, USP USP...
author: USERNAME
Site Index: M-S
CDER Guide to Median Approval Time Statistics (1/31/2003) Conversation with Stakeholders Report-April 1999 (5/19/99) FDA Enforcement Reports Managing the Risks from Medical Product Use: Creating a Risk Management Framework New Drug Approval Reports Prescription Drug User Fee Act Report Fiscal Year 1995 Prescription Drug User Fee Act Report Fiscal Year 1996 Prescription Drug User Fee...
author: Paul Stauffer
Synthetic Conjugated Estrogens, Questions and Answers
NEW DRUG APPROVAL FOR CENESTIN, SYNTHETIC CONJUGATED ESTROGENS, A: MARCH 24, 1999 QUESTIONS AND ANSWERS 1 IS CENESTIN SAFE FOR LONG-TERM USE IS CENESTIN THE SAME AS PREMARIN ISNT IT TRUE THAT FDA REFUSED TO APPROVE SYNTHETIC CONJUGATED ESTROGENS IN MAY OF 1997 Yes, the Agency refused to approve an abbreviated new drug application ...
author: CDERUSERNAME
FDA Drug Approvals List June 2002
- Drug Approvals for June 2002 Definitions and Notes Original New Drug Applications Original Application # 021316 Approval Date: 26-JUN-02 Trade Name: ALTOCOR Chemical Type: 3 Therapeutic Potential: S Dosage Form: TABLET Applicant: AURA LABORATORIES INC Active Ingredient(s): LOVASTATIN OTC/RX Status: RX INDICATION OF USE: For lowering total cholesterol and LDL-C to target levels as...
Premarin
On November 1, 1996, FDA completed a -Preliminary Analysis of Scientific Data on the Composition of Conjugated Estrogens. - On May 1, 1997, the Ad Hoc Conjugated Estrogens Working Group completed its final report providing a scientific background for the Center's decision regarding the composition of conjugated estrogens FDA, Center for Drug Evaluation and...
Annual Comprehensive List of Guidance Documents at the Food and Drug Administration
141 / Friday, July 21, 2000 / Notices Name of Document Date of Issuance Grouped by Intended User or Regulatory Activity How to Obtain a Hard Copy of the Document (Name and Address, Phone, FAX, E- mail or Internet) Consumer- Directed Broadcast Advertisements August 9, 1999 Do Do Antifungal (topical) February 24, 1990 Biopharmaceutic Draft Do Antifungal (vaginal) February 24, 1990 Do...
author: FDA
subject: 7/21/2000
Prescription and OTC Drug Product List 3/1999
Prescription and Over-the-Counter Drug Product List - 19th Edition Cumulative Supplement Number 3: March 1999 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE CALCIUM CHLORIDE; DEXTROSE; GLUTATHIONE DISULFIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CAPSULE; ORAL CHLORIDE; SODIUM PHOSPHATE...
http://www.fda.gov/cber/gdlns/anguidlst.txt
Guidance Documents Issued by the Center for Drug Evaluation and Research (CDER) -------------------------------------------------------------------------------------------------------------------------------------------------------- How to Obtain a Hard Copy of the Document Name of Document Date of Issuance Grouped by Intended User (Name and Address, Phone, FAX, E-mail or or...
http://www.fda.gov/cder/guidance/3668dft.pdf
DOC 02/ 29/ 00 Guidance for Industry Conjugated Estrogens, USP LC- MS Method for Both Qualitative Chemical Characterization and Documentation of Qualitative Pharmaceutical Equivalence Additional copies are available from: Office of Training and Communications Division of Communications Management Drug Information Branch, HFD- 210 5600 Fishers Lane Rockville, MD...
Barr Pharmaceuticals, Inc.
Contact Us Product Guide Drug Information Site Map Key Marketed Proprietary Products - ENJUVIA ™ Duramed's ENJUVIA ™ is an FDA approved once-daily oral estrogen therapy for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. A plant-derived formulation, ENJUVIA ™ contains a blend of 10 synthetic estrogenic substances...
http://www.barrlabs.com/overview/annual/BRL_AR2002.pdf page 5
Pages
Selected Financial Highlights Generic Activities Filed 14 Generic Product Applications TH Generic Premarin® (Conjugated Estrogens) Filed TH Five Patent Challenges Announced 10 New Generic Products Launched TH Five New Generic Oral Contraceptives TH Claravis TM (Generic Accutane®) TH Alternative Brand of Ciprofloxacin TH Tamoxifen, Tambocor, Fludrocortisone...
author: Lisa
Pages page 4
author: Lisa
BioPortfolio Limited
Prescription Generics Report 2003 - 2011 1. Pharmaceutical Manufacturers and the Policy Makers 15.1 Lobbying by Brand-Name and GenericPharmaceutical Companies 15.2 The Importance of Lobbying in the U.S.Pharmaceutical Industry 15.3 Successful Lobbying and Continued Exclusivity with Paediatric Safety Testing 15.4 Generic Pharmaceutical Companies - Second in Line to Branded Pharma...
Drug Information
This information can be used by industry as an aid in developing drug products.- Major Drug Information Pages Accutane (Isotretinoin) Information Page Alimta (pemetrexed for injection) Information Page (2/5/2004) Analgesics: Safe Use of Over-the-Counter Pain Relievers (analgesics) and Fever Reducers (antipyretics) (1/22/2004) Avastin Information Page (2/26/2004) Baycol (cerivastatin)...
author: Carol Assouad
CDER Guidance Documents
(Issued 8/2000, Posted 8/31/2000) Biopharmaceutics (Draft) Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action [ Word ] or [ PDF ] (Posted 4/2/2003) Statistical Information from the June 1999 Draft Guidance and Statistical Information for In Vitro Bioequivalence Data - (Posted 4/11/2003) Clozapine Tablets: In Vivo Bioequivalence and In...